Nonadditivity in public and inhouse data: implications for drug design

D. Gogishvili, E. Nittinger*, C. Margreitter, C. Tyrchan

*Corresponding author for this work

Research output: Contribution to JournalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'Nonadditivity in public and inhouse data: implications for drug design'. Together they form a unique fingerprint.

Chemical Engineering

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology

Neuroscience